Genmab — Januar 2020
-
God morgen.

-
Canada CADTH has issued an initial Reimbursement recommendation for #Daratumumab combination (DRd) https://twitter.com/CADTH_ACMTS/status/1214683188615942144 https://cadth.ca/daratumumab-darzalex-multiple-myeloma?utm_source=CONS+List&utm_campaign=487fd1698e-pCODR-08-01-2019-Keytruda-int-pt_COPY_01&utm_medium=email&utm_term=0_f3b3313866-487fd1698e-263130189
-
Still why is it relevant in a Review? It is relevant to the patient, in marketing and otherwise in accessing toxicity. Thus time is not of essence in a Review like that. The original literature likely have commented on the matter. If I were ask to peer-review this review I would have had it removed by the authors if they started talking about convenience for patients
. -
Så er det vist ved at være oppe over hvis meldingen om de 3mia skal komme!
-
Stockbull. Fordi det er den 8. i dag, og jeg går da ikke ud fra at det tager meget længere tid at få samlet tallene i år end det gjorde sidste år. Det ville da alt andet lige være underligt.
-
Det samlede resultat var 2025, så mon ikke at skæringsdatoen for de 2000 kom ret sent i 2018. På samme måde forventer vi jo også en sen skæringsdato for 2019 (hvis der er en).
-
Men nu må vi se. Det hele er jo software baseret, så derfor går jeg ud fra at timingen er nogenlunde den samme, og at meddelelsen kommer i denne uge (hvis den kommer).
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
